US$267 – $774
| CRISPR Protocols | ALL-Fect and mRNA-Fect reagents for pDNA and mRNA based CRISPR protocols. | ||||
| Transfection kits (1 vial of reagent and 1 vial of Trans-Booster) are recommended for better efficacy in hard-to-transfect cell types. | |||||
| CRISP-Fect for RNP mediated CRISPR protocols | |||||
| SKU | Pack Size (mL) | Concentration (mg/mL) | Price (USD) | ||
| ALL-Fect | 10-10 | 0.75 | 1.00 | 280 | |
| 10-20 | 1.50 | 1.00 | 504 | ||
| ALL-Fect Kit | 10-40 | 0.75 / 0.75 | 1.00 | 400 | |
| 10-50 | 1.5 / 1.5 | 1.00 | 720 | ||
| mRNA-Fect | 80-10 | 0.75 | 1.00 | 310 | |
| 80-20 | 1.50 | 1.00 | 558 | ||
| mRNA-Fect Kit | 80-40 | 0.75 / 0.75 | 1.00 | 430 | |
| 80-50 | 1.5 / 1.5 | 1.00 | 774 | ||
| CRISP-Fect | 90-10 | 0.75 | 1.0 / 0.4 | 267 | |
| 90-20 | 1.50 | 1.0 / 0.4 | 454 | ||
| Benefits | 1. High transfection efficiency in the presence of serum. 2. Effective delivery of pDNA molecules via a simple protocol that is ideal for scale-up and automation. 3. Minimal toxicity compared to other commercial reagents, reducing adverse effects on highly sensitive human cells. 4. Non-integrating transfection reagent eliminates unwanted effects due to host genome integration. 5. Possibility of using the same transfection reagent in animal models, leading to harmonized studies. | ||||
| Property | ALL-Fect, mRNA-Fect, and CRISP-Fect |
| Technology | Polymeric |
| Nucleic Acid | pDNA, mRNA and RNP |
| Cell Types | Attachment-dependent |
| Transfection Type | Transient |
| High Throughput | Compatible |
| Serum | Compatible |
| Buffer | Aqueous |
| Storage Temperature | -20 ºC |
| Shelf Life at -20 ºC | ~1 year |
| Plate Size | Number of Transfections |
|---|---|
| 6-well (1200 µL/well) | 40 – 330 |
| 24-well (800 µL/well) | 60 – 500 |
| 48-well (400 µL/well) | 125 – 1000 |
| 96-well (200 µL/well) | 250 – 2000 |
RJH manufactures a variety of transfection agents for your R&D needs. Download our catalogue for a list of our products.
Automated page speed optimizations for fast site performance